4//SEC Filing
Collier William H. 4
Accession 0001447028-20-000143
CIK 0001447028other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:05 PM ET
Size
9.5 KB
Accession
0001447028-20-000143
Insider Transaction Report
Form 4
Collier William H.
DirectorPresident and CEO
Transactions
- Award
Stock Options
2020-09-23+70,000→ 70,000 totalExercise: $3.35Exp: 2030-02-17→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on February 14, 2020, the trading day immediately preceding the date the performance based option grant was approved by the Executive Compensation and Human Resources Committee of the Board of Directors (the "Committee") of Arbutus Biopharma Corporation, subject to both shareholder approval of an amendment to the Registrant's 2016 Omnibus Share and Incentive Plan (the "Plan Amendment") and the fulfillment of certain performance criteria.
- [F2]The Registrant's shareholders approved the Plan Amendment on May 28, 2020. On September 23, 2020, the Committee determined that the performance criteria had been met.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001780495
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 4:05 PM ET
- Size
- 9.5 KB